EADV Podcast

In this episode of the EADV Podcast, Dr. Sarah Walsh speaks with Prof. Marie-Aleth Richard, incoming President of the European Academy of Dermatology and Venereology (EADV), about her vision for the Academy and her priorities for the years ahead. The conversation explores how the EADV can better support young dermatologists and develop the next generation of leaders, strengthen advocacy for skin health at the European and international levels, and ensure equitable access to education and scientific opportunities for all members. Prof. Richard also discusses the importance of greater international representation and the need to improve gender equality in dermatology, particularly by supporting women in leadership and recognising the different challenges they may face throughout their careers. The episode highlights the importance of collaboration, inclusion, and effective advocacy in shaping the future of dermatology and venereology, while reaffirming the EADV’s role in bringing together a diverse global community to improve skin health and patient care.

Synopsis: In this episode of the EADV Podcast, Dr. Efthymia Soura is joined by Prof. Margarida Gonçalo, Secretary General of the EADV and Head of the Department of Dermatology at the University Hospital of Coimbra, to discuss the Contact Dermatitis Task Force's new paper on chronic hand eczema, written in an accessible question-and-answer format. They cover what defines chronic hand eczema, how to distinguish it from look-alikes such as tinea and psoriasis, and why it functions as an umbrella term covering atopic, irritant and allergic subtypes that often overlap in the same patient. Prof. Gonçalo explains why patch testing (and, where relevant, prick testing) is essential to identify and avoid triggers, and why the different subtypes share a similar molecular signature despite their diverse underlying causes, a finding that for now limits treatment to a largely one-size-fits-all approach. The conversation also addresses the heavy toll chronic hand eczema takes on patients' quality of life, the promise of new topical pan-JAK inhibitors as a possible alternative to steroids, and hope for more personalised, mechanism-based treatments in the future. References: Chronic Hand Eczema: Common Questions and Practical Recommendations from the EADV Contact Dermatitis Task Force (2026) Balato A, Tancredi V, Aerts O, et al. Chronic hand eczema: common questions and practical recommendations from the EADV Contact Dermatitis Task Force. J Eur Acad Dermatol Venereol. 2026;40(4):583-596. doi:10.1111/jdv.70068. 🔗 https://onlinelibrary.wiley.com/doi/10.1111/jdv.70068

In this JEADV Takeaway, Dr. Tom Hillary takes you through "Systemic effects of sunlight: 10-year review of cardiovascular, infection and cancer outcomes" by Jasira A. Ziglar et al., published in the October 2026 issue of JEADV. The full article is available here: https://doi.org/10.1111/jdv.70461

Join Prof. Christian Posch as he presents his selection of Editor’s Picks from the October 2026 issue: Fewer dermatologists = later-stage melanomas JAK-STAT inhibitors and infection risk Marriage as a survival factor in metastatic Merkel cell carcinoma Simulated daylight PDT: pain-free but not powerful enough for actinic keratoses? Read the Editor's Picks here: https://doi.org/10.1111/jdv.70665

In this episode of the EADV Podcast, Dr. Sarah Walsh is joined by Dr. Saskia Oro (Henri Mondor Hospital, Paris) and Dr. Emmanuel Contassot (University of Basel) to mark the launch of the new EADV CARD-EM Task Force. The conversation opens with the newly published European expert consensus on the diagnosis and management of acute generalised exanthematous pustulosis (AGEP), including how to identify severe cases and when oral corticosteroids are warranted over topical treatment. They go on to discuss the allergological work-up for AGEP, including patch testing and lymphocyte transformation tests, and the underlying immunology: Dr. Contassot's research showing that IL-36 and an innate immune pathway, rather than T cells alone, help drive the pustules seen in AGEP. The conversation then turns to epidermal necrolysis (SJS/TEN), covering recent research into the roles of macrophages, dendritic cells and IL-33 in disease progression, and what these findings could mean for the field's first targeted therapies. The episode closes by looking at the long-term impact of SJS/TEN on survivors, drawing on a 2023 Delphi consensus on managing post-acute sequelae and a patient cohort study, both of which point to the same conclusion: the physical and psychological consequences of these diseases can last for decades, and patients need ongoing, multidisciplinary support long after the acute phase has passed. References: AGEP European Expert Consensus (2024) Tetart F, Walsh S, Milpied B, et al. Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management. J Eur Acad Dermatol Venereol. 2024;38(11):2073-2081. doi:10.1111/jdv.20232. 🔗 https://onlinelibrary.wiley.com/doi/10.1111/jdv.20232 Macrophages and Plasmacytoid Dendritic Cells in Epidermal Necrolysis (2025) Saizonou T, et al. Macrophages and plasmacytoid dendritic cells are recruited to the epidermis during epidermal necrolysis. J Eur Acad Dermatol Venereol. 2025. doi:10.1111/jdv.20795. 🔗 https://onlinelibrary.wiley.com/doi/10.1111/jdv.20795 Delphi Consensus on Post-Acute Sequelae of Epidermal Necrolysis (2023) Ingen-Housz-Oro S, Schmidt V, Ameri MM, et al. Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus. Orphanet J Rare Dis. 2023;18:33. doi:10.1186/s13023-023-02631-7. 🔗 https://ojrd.biomedcentral.com/articles/10.1186/s13023-023-02631-7

In this JEADV Takeaway, Dr. Stefania Guida takes you through "Sex disparities in melanoma stage, recurrence and mortality: A Danish cohort study, 2004 to 2024" by J. E. Lyngstrand et al., published in the September 2026 issue of JEADV. The full article is available here: https://doi.org/10.1111/jdv.70180

Join Prof. Carle Paul as he presents his selection of Editor’s Picks from the September 2026 issue: Dose reduction of biologics in psoriasis: giving more freedom to patients Litifilimab for cutaneous lupus erythematosus Managing high impact-site psoriasis: an oral IL-23 Receptor inhibitor on the menu Comorbidities influence treatment response to immune checkpoint inhibitors in squamous-cell carcinoma Read the Editor's Picks here: https://doi.org/10.1111/jdv.70607

In this episode of the EADV Podcast, held on behalf of the EADV Melanoma Task Force, Prof. Monika Arenbergerova is joined by Prof. Zoe Apalla and Prof. Aimilios Lallas to discuss the central role dermoscopy continues to play in melanoma diagnosis. The conversation opens with the newly published International Dermoscopy Society consensus recommendations for the management of lentigo maligna, exploring how dermoscopy and reflectance confocal microscopy guide diagnosis, lesion mapping, and monitoring of treatments such as topical immunotherapy alongside surgery. Together, they discuss the drivers behind melanoma's rising global incidence, striking differences in incidence and access to care across regions, and practical advice for clinicians building their dermoscopy skills, including the common pitfalls facing young dermatologists. The conversation also touches on how AI-powered digital biomarkers build on dermoscopy to help predict prognosis, and how each guest weighs sensitivity against specificity when deciding whether to biopsy. The episode closes with both speakers agreeing on what matters most for improving outcomes: faster access to specialists and earlier diagnosis of melanoma. References: International Dermoscopy Society Consensus Recommendations for the Management of Lentigo Maligna (2026) Forsea AM, et al. International Dermoscopy Society consensus recommendations for the management of lentigo maligna. J Eur Acad Dermatol Venereol. 2026. doi:10.1111/jdv.70406. 🔗 https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.70406

In this JEADV Takeaway, Dr. Prajwal Pudasaini takes you through "Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact" by Ziehfreund S et al., published in the August 2026 issue of JEADV. The full article is available here: https://doi.org/10.1111/jdv.70245

Join Prof. Dr. Emek Kocatürk as she presents her selection of Editor’s Picks from the August 2026 issue: Exosomes in dermatology: hype, hope and evidence CSU: the family burden behind the flare The eczema that was not: CTCL red flags before dupilumab Amivantamab-associated dermatologic toxicities: watch for ulcerative lesions Read the Editor's Picks here: https://doi.org/10.1111/jdv.70558

In this episode of the EADV Podcast, Prof. Michela Starace, Chair of the EADV Hair Diseases Task Force, is joined by Task Force Co-Chairs Prof. Alexander Katoulis and Dr. Matilde Iorizzo to discuss current perspectives on scarring alopecias and the challenges of diagnosis and management. The conversation explores the relationship between lichen planopilaris and frontal fibrosing alopecia, highlighting ongoing debates around their classification, clinical presentation, and treatment approaches. The speakers also discuss the value of trichoscopy in everyday practice, the importance of early recognition of inflammatory activity, and the role of consensus-driven guidance in supporting clinicians faced with complex cases. Looking ahead, the experts examine emerging therapeutic strategies, including the potential role of JAK inhibitors, while reflecting on the need for further evidence and long-term data. The episode highlights the importance of recognising the emotional and psychosocial impact of hair disorders, while encouraging clinicians to adopt a patient-centred approach to care. Through practical insights, shared experiences, and discussion of emerging developments, the speakers underline the value of education, collaboration, and empathy in improving outcomes for people living with alopecia and other hair diseases. References: Seyed Jafari SM, Starace M, Katoulis A, et al. Management of classic lichen planopilaris: The EADV Task Force on Hair Diseases position statement. Journal of the European Academy of Dermatology and Venereology (JEADV). Published online 18 March 2026. DOI: 10.1111/jdv.70379. Waśkiel-Burnat A, Starace M, Iorizzo M, Katoulis A, et al. Management of folliculitis decalvans: The EADV Task Force on Hair Diseases position statement. Journal of the European Academy of Dermatology and Venereology (JEADV). 2025;39(8):1385–1394. DOI: 10.1111/jdv.20687 Starace MVR, Pampaloni F, Iorizzo M, Katoulis A, et al. Delphi Consensus on the Distinct Clinical and Histopathological Features of Lichen Planopilaris and Frontal Fibrosing Alopecia: Insights From the Hair Diseases EADV Task Force. International Journal of Dermatology. 2025;64(7):1246–1254. DOI: 10.1111/ijd.17780.

In this JEADV Takeaway, Dr. Willemijn Witkam takes you through "Healthy plant-based dietary pattern is associated with a lower risk of rosacea" by Zhang et al., published in the July 2026 issue of JEADV. The full article is available here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70163

Join Prof. Carle Paul as he presents his selection of Editor’s Picks from the July 2026 issue: An expert consensus on treat-to-target criteria for chronic prurigo Evidence-based European guidelines for the treatment of acne Denifanstat for moderate to severe acne: a potential alternative to isotretinoin? JAK inhibitors for non-infectious granulomatous skin diseases Read the Editor's Picks here: https://doi.org/10.1111/jdv.70472

In this special Pride Month episode of the EADV Podcast, Dr. Tiago Matos and Prof. Myrto Trakatelli explore why inclusion, visibility, and affirming care matter in dermatology and venereology today more than ever. Through an open and honest conversation, they discuss how everyday clinical interactions, communication, and representation can directly influence patient trust, healthcare access, and long-term outcomes for LGBTQI+ communities. From creating safer consultation spaces to recognising unconscious bias and improving medical education, the speakers reflect on the responsibility healthcare professionals have in delivering truly patient-centred care. The discussion also highlights the importance of allyship, empathy, and visibility in helping patients feel seen, respected, and supported throughout their healthcare journey. This episode highlights the value of honesty, vulnerability, and allyship in medicine, while encouraging healthcare professionals to create safer and more welcoming environments for every patient. A thoughtful discussion on representation, education, and the human side of dermatological and venereological care.

Join Prof. Rolland Gyulai as he presents his selection of Editor’s Picks from the June 2026 issue: First oral TNFR1 inhibitor for mild-to-moderate psoriasis Adjuvant treatment with immune checkpoint inhibitors - no benefit in acral melanomas Simple biomarkers predict favourable treatment response Mogamulizumab-associated rash – new insights into pathogenesis Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70448

In this episode of the EADV Podcast, Dr. Antonio Torrelo speaks with Dr. Andrea Diociaiuti, contributor to the recent JEACP Special issue on cutaneous mosaicism, to explore one of the most fascinating concepts in dermatology and genetics. Together, they discuss how mosaicism shapes the skin, the clinical patterns that help physicians recognise these conditions, and how advances in genetic sequencing are transforming diagnosis and patient care. The conversation also delves into the broader implications of mosaicism beyond the skin, the importance of careful clinical observation, and the increasing potential of precision medicine and targeted therapies. This episode offers listeners an accessible and forward-looking overview of a rapidly evolving field that is changing the way dermatologists understand genetics, skin biology, and personalised medicine. Read the Special Issue: https://onlinelibrary.wiley.com/toc/27686566/2025/4/3

Join Prof. Carle Paul as he presents his selection of Editor’s Picks from the May 2026 issue: Management of cutaneous immune adverse events associated with immune check point inhibitors (ICI) Pregnancy-associated melanoma: no additional risk of progression Long-term treatment with nemolizumab for atopic dermatitis Management of cutaneous lupus: state of the art Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70409

In this episode of the EADV Podcast, Dr. Azael Freites Martinez is joined by Prof. Zoe Apalla and Dr. Vincent Sibaud for a practical discussion on the dermatologic adverse events associated with immune checkpoint inhibitors. Together, they explore why the skin is so commonly affected, how to recognise the most frequent reactions in daily practice, and when cancer patients should be referred to a dermatologist. The conversation also highlights current management strategies for pruritus, eczematous, psoriasiform and lichenoid reactions, with a focus on accurate diagnosis, multidisciplinary collaboration, and the growing role of targeted and biologic therapies in supportive oncodermatology. The episode closes with an important reminder: many of these skin reactions are manageable, and timely dermatologic care can make a meaningful difference to both quality of life and cancer treatment continuity.

Join Sarah Walsh as she presents her selection of Editor’s Picks from the April 2026 issue: Robust data supporting biologics in paediatric psoriasis Economically encouraging results for biologics in hidradenitis suppurativa News about scabies and tips for ticks! Pain control in SJS/TEN may protect against PTSD Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70342

In this episode of the EADV Podcast, Dr. Sarah Walsh speaks with guest editors Prof. Jo Lambert and Prof. Curdin Conrad about the JEADV Special issue on Personalised Medicine. They explore how dermatology is moving from trial-and-error treatment toward stratified and precision approaches, particularly in psoriasis and hidradenitis suppurativa, with the aim of delivering the right treatment to the right patient at the right time. The discussion also addresses important challenges, including cost, accessibility, and health equity, offering a balanced and forward-looking perspective on how personalised medicine may reshape everyday clinical practice. This episode offers an exploration of how personalised medicine is reshaping dermatology, scientifically, clinically, and ethically, and what it means for everyday patient care.